Loading Events

The Impact of Menopause on Women’s Health: A Work-Life-Health Initiative

  • This event has passed.

January 27, 2025 - January 28, 2025

Menopause is a universal life stage for women with far-reaching economic, social, and health care implications on their personal and professional lives. Approximately 6000 women reach menopause every day, and many with symptoms that range from hot flashes and genitourinary symptoms to brain fog and sleep disturbances.

Despite the vast number of women experiencing life disruptions during the menopause transition, accessible treatment options and education to navigate their care are limited. Moreover, according to the U.S. Bureau of Labor Statistics, women aged 45-54 years have a 75% participation rate in the labor workforce. With the average age of menopause being 51, it is important for employers to recognize women’s health experiences, especially during the menopause transition, for optimal talent recruitment and retention. SWHR’s Employee Perspectives and Challenges Concerning the Transition of Menopause (EMPACT Menopause) Study found that only 3% of employees or supervisors reported having menopause-specific policies in place at work. Organizational support in promoting midlife health and wellness and enabling women, their coworkers, and employers to contribute to its values and success is key to managing menopause in the workplace for inclusive and productive work environments for all employees.

SWHR convened an interdisciplinary Menopause Equity Working Group of health care providers, researchers, patient advocates, human resource specialists, and health care policy leaders for a closed, roundtable meeting in January 2025. During the roundtable, the Working Group discussed the impact of menopause on women’s health, with an emphasis on navigating patient care and the workplace.

This is an SWHR Event.

Details

Organizer

Objectives

The objectives of the roundtable are to:

  • Address the impact of menopause on women’s health, including associated symptoms, comorbidities, and stigma experienced by women undergoing the menopause transition
  • Promote science-based health care policies around menopause to improve patient outcomes
  • Participate in outreach opportunities to engage health care providers, employers, and policy leaders in discussions to improve care for perimenopausal and postmenopausal women
  • Strategize how employers, coworkers, and workplace policies can better support women working throughout the menopause transition
  • Develop materials to expand education, raise awareness, and improve quality of life for women undergoing menopause

Working Group Participants

Carleeka Basnight-Menendez, BS, Founder, INSO Inc

Jessica Brooks-Woods, MPM, PHR, Chief Executive Officer, National Association of Benefits and Insurance Professionals

Jennifer Chiang, MS, SHRM-SCP, Head of Global People Strategy Realization, MilliporeSigma

Monica Christmas, MD, Associate Professor of Obstetrics and Gynecology, University of Chicago

Yamnia I. Cortés, PhD, MPH, RN, FAHA, FAAN, Associate Professor, College of Nursing, University of Iowa College

Jennifer Fairweather, DBA, SHRM-SCP, IPMA-SCP, PHR, Chief Human Resources Officer, Jefferson County, Colorado

Stephanie S. Faubion, MD, MBA, FACP, MSCP, IF, Medical Director, The Menopause Society, Penny and Bill George Director, Mayo Clinic Center for Women’s Health, Professor and Chair, Department of Medicine, Mayo Clinic

Kavita Joshi, CLSSSB, Program Manager, Training and Technology, Customer Solutions Group, AARP

Susan Kulp Randall MSN, FNP, Board Member, National Menopause Foundation

Mache Seibel, MD, Founding Editor, The Hot Years Magazine, HealthRock LLC

Sharon Seibel, MD, Associate Editor, The Hot Years Magazine, HealthRock LLC

Wen Shen, MD, MPH, Associate Professor, Johns Hopkins University School of Medicine

Jack B. Tuckner, Esq, Founding Partner, Tuckner, Sipser, Weinstock & Sipser, LLP

Kamili Wilson, Chief Executive Officer & Founder, Menopause Made Modern by Claret Circle

Sponsor

Support for this educational program has been provided by Astellas Pharma, Bayer, and Pfizer. SWHR maintains independence and editorial control over program development, content, and work products.

Astellas logo
Bayer Logo